GSK Investigational Site

Seabrook, Texas 77586

2 studies enrolling now · 2 studies all time

What they study most

Non-alcoholic Fatty Liver Disease

Studies at this site

• A Clinical Study to Investigate the Safety and Tolerability of Efimosfermin Alfa Injection in Participants With Known or Suspected F2- or F3-stage MASH — Recruiting now
• A Pivotal Clinical Study to Investigate Efimosfermin Alfa in Participants With Biopsy-confirmed F2- or F3-stage MASH — Recruiting now